Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
Crossref DOI link: https://doi.org/10.1007/s40744-017-0083-1
Published Online: 2017-09-27
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Borse, Rebekah H.
Brown, Chloe
Muszbek, Noemi
Chaudhary, Mohammad Ashraf
Kachroo, Sumesh
Funding for this research was provided by:
Merck & Co., Inc.
Article History
Received: 26 June 2017
First Online: 27 September 2017